跳转至内容
Merck

E-018

Supelco

(±)-N-Ethylamphetamine solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C11H17N
CAS号:
分子量:
163.26
EC號碼:
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24

等級

certified reference material

形狀

liquid

特點

Snap-N-Spike®/Snap-N-Shoot®

包裝

ampule of 1 mL

製造商/商標名

Cerilliant®

drug control

Narcotic Licence Schedule B (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)

濃度

1.0 mg/mL in methanol

技術

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

應用

forensics and toxicology

形式

single component solution

儲存溫度

2-8°C

SMILES 字串

CCNC(C)Cc1ccccc1

InChI

1S/C11H17N/c1-3-12-10(2)9-11-7-5-4-6-8-11/h4-8,10,12H,3,9H2,1-2H3

InChI 密鑰

YAGBSNMZQKEFCO-UHFFFAOYSA-N

一般說明

N-Ethylamphetamine is a stimulant drug of the phenethylamine and amphetamine classes. This certified solution standard is suitable for use as starting material in calibrators or controls for a variety of LC/MS or GC/MS applications from sports testing and clinical toxicology to forensic analysis and urine drug testing. N-Ethylamphetamine, sold as the pharmaceutical appetite-suppressant Apetinil, is also abused as a recreational drug with a stimulant effect similar to that of its amphetamine and methamphetamine analogs.

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

相關產品

产品编号
说明
价格

訊號詞

Danger

危險分類

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

標靶器官

Eyes

儲存類別代碼

3 - Flammable liquids

水污染物質分類(WGK)

WGK 1

閃點(°F)

49.5 °F - closed cup

閃點(°C)

9.7 °C - closed cup


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Gabriele Cruciani et al.
Journal of medicinal chemistry, 48(22), 6970-6979 (2005-10-28)
Identification of metabolic biotransformations can significantly affect the drug discovery process. Since bioavailability, activity, toxicity, distribution, and final elimination all depend on metabolic biotransformations, it would be extremely advantageous if this information could be produced early in the discovery phase.
K Matsushima et al.
Nihon hoigaku zasshi = The Japanese journal of legal medicine, 52(1), 19-26 (1998-05-20)
Characterization of optical activity and simultaneous analysis of racemic ethylamphetamine (EAMP) and its metabolites, as well as the urinary excretion of the optical isomers, were examined in rats by high-performance liquid chromatography (HPLC). Analysis of the optical isomers of EAMP
A Dasgupta et al.
Journal of forensic sciences, 43(3), 636-640 (1998-06-03)
Phenmetrazine is a central nervous system stimulant currently used as an anorectic agent. The drug is abused and is reported to cause death from overdose. We describe a new derivatization method for phenmetrazine using 4-carbethoxyhexafluorobutyryl chloride. Quantitation of urinary phenmetrazine
F T Delbeke et al.
Arzneimittel-Forschung, 36(9), 1413-1416 (1986-09-01)
The urinary excretion of etilamfetamine (ethylamphetamine) and its major metabolite amphetamine in humans was followed over a period of several days after the oral administration of two formulations. The excretion of both substances was affected by urinary pH. Excretion peaks
T Nagai et al.
Journal of analytical toxicology, 19(4), 225-228 (1995-07-01)
The analysis of time-lapse changes of d- and l-enantiomers after administration of racemic dl-ethylamphetamine (EAMP) to rats was performed by a high-performance liquid chromatograph equipped with a chiral activity column. After oral administration of dl-EAMP to five rats (dose, 15

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门